01
Embedded Medical Monitor
Our co-founder and CMO, Dr. Dipali Patel, is an experienced medical monitor closely with our site investigators. Any questions get an expert level response quickly, not automated replies.
For Sponsors And CROs
Our sites may already have the patients you Are looking For.
Stryde clinical research sites are embedded within specialty practices, owned by physicians with years of clinical experience and subject matter knowledge, and more importantly, extensive knowledge of their patients' history. Our investigators and dedicated patient recruitment specialists work together to shorten enrollment timelines, evidenced by our published numbers.
Request FeasibilityShort Answer: Keep Stryde in mind when your protocol needs patient enrollment in outpatient specialty therapeutic areas, when diversity targets matter, or when your study needs additional rescue sites. Our organization is fully integrated into community (or physician-owned) specialty practices that routinely see potentially eligible patients. These patients place their trust in their provider, and our physician investigators put their trust in us to operate seamlessly within their practice.
What Do You Get That A Site List Can’t Show?
02
Diversity By Design, Not By Campaign
Our practices serve the community they reside, with enrollment and treatment diversity an integral part of our model.
03
Cell And Gene Ready
NIH IBC-RMS approval for advanced therapy studies.
04
One Contract, Many Sites
Multi-regional investigator network operate under a single organization, with central regulatory, quality and finance teams supporting clinical operations at each of our sites.
Benchmarks are on our performance board; see the full community-versus-academic comparison.
How Do We Build Enrollment Numbers?
Bottom-up, never from prevalence. Active patient counts from practice EMRs, protocol filters applied in sequence, realistic screen-failure rates by study type, and coordinator capacity applied as a hard ceiling. The result is a number we would actually commit to. The full method, with a worked example, is on how we build an enrollment number.
When Should A Sponsor Choose A Community Site Over An Academic Site?
Stryde Embedded Sites
Academic Medical Centers
01
Best For
Outpatient enrollment at the treatment-decision moment; diversity targets; rescue timelines
Complex inpatient protocols; first-in-human units; KOL-anchored science
02
Patient Source
The practice's own panel, already in the EMR
Referrals, often after key treatment decisions were made elsewhere
03
Startup
6.5-week network median; as fast as two weeks when sponsor needs and documents allow
Published medians of 69 days (university) to 167 days (cancer centers)
04
Retention Driver
Existing physician relationship; visits at the patient's usual clinic
Study-built relationship
Benchmark sources are on the performance board; read the full community sites vs academic centers comparison.
Where Are We A Strong Fit, And Where Aren’t We?
Inpatient Phase 1 and Outpatient Phase 2–4 in dermatology, rheumatology, and our active specialties.
Studies with modalities that require an infusion or injectable protocol with cold chain storage in place.
Rare disease work where Community Specialists hold the panel.
Protocols with FDA diversity action plan targets.
Studies needing rescue sites with pre-tagged eligible patients.
Indications requiring infrastructure our practices do not offer; an academic site may serve you better, and we will say so in the feasibility response.
Therapeutic Coverage
Dermatology
Rheumatology
Cardiology
Pulmonology
Neurology
Endocronology
Ophthalmology
Allergy & Immunology
Cardiometabolic
Pediatrics
Send Us Your Protocol Synopsis. Preliminary Feasibility In 48 Business Hours, Or We’ll Tell You Why Not Within 4.
Frequently Asked Questions (FAQs)
Stryde Research is a physician-owned Site Management Organization (SMO+) that runs clinical trials inside specialty physician practices. The network spans 20+ embedded research sites across Texas, Louisiana, New Jersey, and New York, with access to 1.5M+ patients across 100+ specialty clinics.
A dedicated facility recruits unfamiliar patients through advertising. An embedded site places research staff inside an existing specialty practice, so eligible patients are already in the EMR and already trust the investigator. The result is faster startup, faster enrollment, and better retention.
Preliminary feasibility in 48 business hours, or an honest answer within 4 hours explaining why a protocol needs longer. Preliminary includes PI interest, an estimated eligible population from network data, a realistic enrollment range, and capability fit.
Yes. The network holds NIH IBC-RMS approval for advanced therapy trials, alongside experience across dermatology, rheumatology, neurology, pulmonology, and additional specialties.
By geography rather than campaigns. Our sites sit inside community practices serving South Asian, Black, Hispanic, and immigrant communities across our markets, so representative enrollment is a structural feature of the model, not an advertising outcome.
Want outcomes, not claims? See network results. Before the pitch, see our live performance metrics, enrollment results from real studies, or the way we build enrollment numbers.